Search

everythinglearnresearchcommunity

for

Search:↓

Platelet-rich plasma treatment significantly increased hair regrowth and decreased discomfort in alopecia patients, making it a potentially better and safer treatment option.

Dermatologists need to understand African American hair-care practices to better treat their hair and scalp disorders.

Alopecia areata can cause unpredictable hair loss, and treatments like corticosteroids and minoxidil may help but have varying side effects.

Tofacitinib 2% ointment helped hair regrow in 3 out of 10 patients with alopecia areata, but caused side effects like scalp irritation and raised cholesterol in some.

Men with early hair loss have similar hormone levels to women with PCOS, possibly increasing risk of obesity and heart issues.

Finasteride reduces Tourette syndrome symptoms, but results may be limited due to potential biases.

Topical immunotherapy, especially with DPCP, is effective for treating severe alopecia areata.

No systemic treatment for alopecia areata has strong evidence of effectiveness.

Oral minoxidil effectively reduces hair shedding in women with CTE, with no major side effects.

Finasteride may help reduce symptoms in male Tourette syndrome patients.

Minoxidil doesn't affect perifollicular lymphoid infiltration in alopecia areata patients.

Hair loss in lupus is different from hair loss in alopecia areata and may indicate lupus activity.

Men taking dutasteride or finasteride have a slightly higher risk of developing type 2 diabetes.

Photodynamic therapy with methyl 5-aminolevulinic acid is ineffective for treating alopecia totalis.

Alopecia areata significantly lowers quality of life, especially in personal and social areas, and more so if the patient is also depressed.

Oral ciclosporin A and topical treatments both reduce hair loss and scaling in dogs with sebaceous adenitis, but using both together is most effective.

Finasteride significantly reduced tics and obsessive-compulsive symptoms in patients with Tourette syndrome.

Different treatments for alopecia areata have unpredictable results and varying success rates.

The erbium-glass laser effectively promotes hair regrowth in alopecia areata.

Latanoprost works better for hair growth, and combining it with betamethasone valerate is most effective.

Patients with schizophrenia have a high rate of skin diseases, with fungal infections and dermatitis being most common, and those on clozapine have a lower risk of fungal infections.

Advanced therapies like gene, cell, and tissue engineering show promise for hair regrowth in alopecia, but their safety and effectiveness need more verification.

PRP did not significantly regrow hair in alopecia areata totalis patients.

Genomic approach finds new possible treatments for hair loss.

Tofacitinib works better and is more tolerable for severe alopecia than conventional treatments and DPCP immunotherapy.

Minoxidil and spironolactone combo effectively treats androgenetic alopecia, improving hair density and diameter.

Both methods improve hair density and thickness; double-spin may be more effective.

LALPS causes non-scarring hair loss along the Blaschko line, with unique trichoscopic findings.

The conclusion is that in the Indian subcontinent, socioeconomic status, stress, and family structure affect the severity of alopecia areata, and its psychological impact is generally mild or moderate.

Boxer dogs may have a genetic skin condition that worsens seasonally and can be treated with certain medications.